Morino A, Nakamura A, Nakanishi K, Tatewaki N, Sugiyama M
Xenobiotica. 1985 Dec;15(12):1033-43. doi: 10.3109/00498258509049098.
After i.v. injection of camazepam, plasma camazepan concn. declined biexponentially. The half-life of the elimination phase (t1/2, beta) increased in the order: mice (0.73 h), rats (1.3 h), dogs (5.3 h). After oral dosing of camazepam, absorption was almost complete whereas systemic availability varied eight-fold, i.e., rats and mice (10-15%) less than dogs and monkeys (about 60%) less than humans (greater than 90%), indicating species difference in the first-pass effect. Camazepam was metabolized extensively in all species investigated to more than 10 metabolites, which were desmethyl, descarbamoyl and/or hydroxy products. In comparison with camazepam, plasma concn. of pharmacologically active metabolites, temazepam, oxazepan and hydroxy camazepam, were much higher in rats and mice than in dogs and monkeys.
静脉注射卡马西泮后,血浆中卡马西泮浓度呈双指数下降。消除相半衰期(t1/2,β)按以下顺序增加:小鼠(0.73小时)、大鼠(1.3小时)、犬(5.3小时)。口服卡马西泮后,吸收几乎完全,但全身可用性相差8倍,即大鼠和小鼠(10 - 15%)低于犬和猴(约60%)低于人类(大于90%),表明首过效应存在种属差异。在所有研究的物种中,卡马西泮都被广泛代谢为10多种代谢物,这些代谢物是去甲基、去氨甲酰和/或羟基产物。与卡马西泮相比,药理活性代谢物替马西泮、奥沙西泮和羟基卡马西泮的血浆浓度在大鼠和小鼠中比在犬和猴中高得多。